Table S2 from Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis

Testa, Stefano; Bui, Nam Q.; Ganjoo, Kristen N.

doi:10.1158/2767-9764.23664956.v1

Table S2 from Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis

journal contribution

posted on 2023-07-12, 02:20 authored by Stefano Testa, Nam Q. Bui, Kristen N. Ganjoo

Table S2 shows the results of molecular testing available for each patient in the study.

Funding

n/a

History

ARTICLE ABSTRACT

This study examines systemic treatments for advanced PEComas, a rare group of sarcomas, and identifies molecular biomarkers of prognosis. Our results show that mTOR inhibitors have similar efficacy as chemotherapy, and that TFE3 overexpression, on IHC or FISH, correlates with a more aggressive disease course.